Toxic Gets More Shows Than Irumudi at Ravi Teja’s Theatre

Core News & Key Facts

Mass Maharaja Ravi Teja’s Irumudi is reportedly continuing its strong theatrical run after receiving an excellent response from audiences. The film has been performing well at the box office, with trade circles expecting it to maintain strong collections based on its positive word of mouth. Reports also indicate that the movie has been recording houseful shows in several areas even on weekdays, adding to expectations surrounding its overall theatrical performance.

However, the arrival of Yash-starrer Toxic in the Telugu states has created a new situation for Irumudi. With the makers of Toxic aiming for a wide release, there had been speculation that Irumudi could lose some screens. The latest show allocations appear to support those expectations, with Toxic receiving a significant number of shows across Telugu-speaking markets.

Context & Official Statements

One of the most interesting developments has emerged from Hyderabad, where Ravi Teja’s ART theatre is also located. According to the reported schedule, the theatre has allocated 15 shows in total today, with 10 shows going to Toxic and five shows to Irumudi. The allocation means Toxic has received twice as many shows as the Ravi Teja starrer at this particular venue.

The development has naturally attracted attention because ART is associated with Ravi Teja. Some observers have pointed out the unusual nature of Toxic receiving greater priority than Irumudi at a theatre linked to the actor. However, the scheduling can also be viewed in the context of Toxic’s release day, when newly released films typically receive a larger number of shows to accommodate initial audience demand.

Impact & What to Expect Next

The show distribution could influence the short-term theatrical availability of Irumudi in Hyderabad, particularly if demand remains strong. The film’s reported houseful weekday shows suggest that there is still considerable audience interest, and reducing its show count could potentially leave some demand unmet.

At the same time, Toxic is entering theatres with a major release strategy and is expected to occupy a substantial share of screens during its opening phase. The immediate priority given to the new release is therefore not necessarily an indication of Irumudi’s long-term theatrical position.

The key point of interest will be the schedule from tomorrow onward. If Irumudi continues to record strong occupancy while Toxic’s initial demand settles, theatres could potentially adjust the number of shows accordingly. The coming days will reveal whether Toxic maintains its dominant show allocation or whether Irumudi regains some of its screens based on audience response and occupancy.